URP is pleased to welcome PSC Biotech to the Park. The California-based company, which specializes in making cancer-fighting drugs, will move into the former Mentor Biologics building and plans to hire over 100 positions. Drug production is slated to begin in 2015....
Madworks Coworking's accelerator program, "Madworks at Campus" is offering grants of up to $4,000 for early stage startups to participate in a high energy 10-week lean startup class that provides structure and mentoring, helping these new businesses determine their viability in the marketplace....
Apply to pitch your company to the most active investors in the Midwest at the annual Wisconsin Early Stage Symposium!...
Imbed Biosciences Inc., a Madison company with a novel biomaterials platform for wound dressings and surgical implants, has raised $683,000 of a planned $1 million funding round, according to filings with federal securities regulators....
Cellular Dynamics International Inc. said Thursday it has been granted a U.S. patent on the automated production of cells that can be grown into any of the more than 200 types of cells in the body....
The Morgridge Institute Medical Engineering team, responding to increased UW-Madison demand for microfluidics resources, has launched a new microfluidics foundry to build customized tools that bring biology down to the smallest possible scale....
Aaron Olver, who will take over as head of University Research Park next month, says he'll be working over the next year on an updated strategic blueprint as URP's new site gears up for business....
Exact Sciences Corp. announced that Mayo Clinic will be the first health system to offer Cologuard®, the first and only Food and Drug Administration (FDA) approved, noninvasive stool DNA screening test for colorectal cancer....
Silatronix, a Madison-based startup working to make lithium ion batteries safer and more efficient, has secured $2.8 million in venture funding....
Following the recent FDA approval of Exact Sciences' Cologuard® product, the first non-invasive, DNA screening test for colorectal cancer, the company must convince healthcare providers and consumers of the effectiveness of the product....
Exact Sciences Corp. (NASDAQ: EXAS) announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test....
BIOforward, the member driven, Wisconsin affiliate of the national Biotechnology Industry Organization (BIO) today announced it has initiated a national search for a Chief Executive Officer. ...